IGM Biosciences Analyst Ratings
BofA Securities Initiates IGM Biosciences(IGMS.US) With Hold Rating
Bank of America Securities Sticks to Their Hold Rating for IGM Biosciences (IGMS)
Express News | IGM Biosciences Inc : JP Morgan Raises to Neutral From Underweight
IGM Biosciences Downgraded to Hold From Buy at Jefferies
IGM Biosciences IGMS -65% Workforce & Pipeline Reduction; Senseonics SENS +76% Preliminary Revenue
J.P. Morgan Upgrades IGM Biosciences(IGMS.US) to Hold Rating
IGM Biosciences IGMS Development Halt; Precision BioSciences DTIL Phase 1/2 Data
IGM Bio Plunges as Wall Street Downgrades on Portfolio Shakeup
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
Top Midday Decliners
IGM Biosciences Cut to Hold From Buy by Jefferies
IGM Biosciences Shares Drop 68% as Company Halts Key Programs and Cuts Workforce
IGM Biosciences Price Target Cut to $2.00/Share From $12.00 by Truist Securities
IGM Biosciences Is Maintained at Hold by Truist Securities
Stifel Downgrades IGM Biosciences to Hold, Lowers Price Target to $2.5
RBC Capital Downgrades IGM Biosciences to Sector Perform, Lowers Price Target to $1.5
Jefferies Downgrades IGM Biosciences to Hold From Buy, $2 Price Target; Shares Plunge
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December
Morgan Stanley Downgrades IGM Biosciences to Underweight From Equalweight, Adjusts PT to $2 From $12